1-3 of 3
Anna R K Franklin
Close
Sort by
Journal Articles

Population Pharmacokinetics (PPK) and Exposure-Response to Support Body Surface Area (BSA)-Based Dosing of Brentuximab Vedotin in Pediatric Patients with Advanced-Stage Newly-Diagnosed Hodgkin Lymphoma (HL)

Xiaofei Zhou, Diane R Mould, Anna R K Franklin, Lia Gore, Xiang Bai, Neeraj Gupta
Journal: Blood
Blood (2022) 140 (Supplement 1): 3724–3725.
https://doi.org/10.1182/blood-2022-160105
Published: 2022
Journal Articles

Augmented Berlin-Frankfurt-Muenster Based Therapy For Young Adults With Acute Lymphoblastic Leukemia (ALL)

Michael E. Rytting, MD, Deborah A. Thomas, MD, Susan O'Brien, MD, Kurt Schroeder, RN, Rebecca Garris, BSc, Jorge E. Cortes, MD, Farhad Ravandi, MD, Naveen Pemmaraju, MD, Naval Daver, MD, Stefan H. Faderl, MD, Anna R. K. Franklin, MD, Gautam Borthakur, MBBS, Steven M. Kornblau, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2013) 122 (21): 1400.
https://doi.org/10.1182/blood.V122.21.1400.1400
Published: 2013
Journal Articles

Absence of donor T-cell–derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity

Brief Report
Chiara Borsotti, Anna R. K. Franklin, Sydney X. Lu, Theo D. Kim, Odette M. Smith, David Suh, Chris G. King, Andrew Chow, Chen Liu, Onder Alpdogan, Marcel R. M. van den Brink
Journal: Blood
Blood (2007) 110 (2): 783–786.
https://doi.org/10.1182/blood-2006-10-054510
Published: 2007
Includes: Supplemental data